Novartis To Purchase Gyroscope Therapeutics
The Swiss pharmaceutical company Novartis announced that they are going to purchase Gyroscope Therapeutics, a United Kingdom ocular gene therapy company.
The Swiss pharmaceutical company Novartis announced that they are going to purchase Gyroscope Therapeutics, a United Kingdom ocular gene therapy company.